Spinal Restoration, Inc. and Baxter Healthcare Corporation Announce Agreement for Developing Spinal Disc Application

AUSTIN, Texas--(BUSINESS WIRE)--Spinal Restoration and Baxter Healthcare Corporation (NYSE:BAX) have entered into an exclusive, long-term partnership to develop and commercialize Biostat BIOLOGX™ Fibrin Sealant, a key element of Spinal Restoration’s new biologic therapy for chronic low back pain. Baxter’s fibrin sealant will be combined with the Company’s proprietary technologies to create the Biostat™ Disc Augmentation System, a minimally invasive product that will be developed and tested for the treatment of painful degeneration of intervertebral discs.

MORE ON THIS TOPIC